News Karnataka
Saturday, February 04 2023
North America

Ottawa: Canada approves first bivalent Covid-19 booster

Canada approves
Photo Credit : IANS

Ottawa: Health Canada has authorised an adapted version of the Moderna Spikevax Covid-19 vaccine which targets the original SARS-CoV-2 virus from 2019 and the Omicron (BA.1) variant.

According to a statement issued by the agency on Thursday, this vaccine, known as a “bivalent” vaccine, is authorised for use as a booster dose in individuals aged 18 years or above.

This is the first bivalent Covid-19 vaccine authorised in Canada, said the agency, adding that the bivalent Moderna Spikevax booster is safe and effective with the same mild adverse reactions that resolved quickly, Xinhua news agency reported.

Clinical trial results showed that a booster dose of the bivalent Moderna Spikevax vaccine triggers a strong immune response against both Omicron (BA.1) and the original SARS-CoV-2 virus strain, the agency added.

It was also found to generate a good immune response against the Omicron BA.4 and BA.5 subvariants, and is expected to extend the durability of protection, Health Canada said.

Share this:
MANY DROPS MAKE AN OCEAN
Support NewsKarnataka's quality independent journalism with a small contribution.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Leave a Reply

Your email address will not be published. Required fields are marked *

Rohan City Corp
Rohan City Corp

Find the best odds at 10Cric and IPL Betting 2023! Signup today and get up to a 100% deposit bonus.

To get the latest news on WhatsApp